{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-048801","form_type":"8-K","ticker":"LFVN","cik":"0000849146","company_name":"Lifevantage Corp","filed_at":"2025-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.356006+00:00","generated_at":"2026-05-17T00:47:06.173772+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"LifeVantage Q1 FY2026 revenue $47.6M (+0.7%), EPS $0.17 vs $0.14 a year ago","bullets":["Net income $2.2M ($0.17 diluted EPS); adjusted EPS $0.18 vs $0.15.","Adjusted EBITDA $3.9M, down from $4.4M a year earlier.","Americas revenue +0.8%; Asia/Pacific & Europe revenue +0.4% (constant currency -1.4%).","Declared $0.045/share cash dividend payable Dec 15, 2025 to holders of record Dec 1, 2025.","Reaffirmed FY2026 guidance: revenue $225-240M, adj. EBITDA $23-26M, adj. EPS $1.00-1.15."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-048801","json":"https://secwatch.observer/filing/0001628280-25-048801.json","markdown":"https://secwatch.observer/filing/0001628280-25-048801.md","text":"https://secwatch.observer/filing/0001628280-25-048801.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/849146/000162828025048801/0001628280-25-048801-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/849146/000162828025048801/lfvn-20251104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:47:06.173772+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}